Sterling Pharma Solutions

Activities: Manufacturing Ingredients

Trending Articles

  1. Novel innovation enhances productivity and output for Polish pharma company A consultative approach to service, delivery and problem solving ensured that a Polish pharmaceutical company received the equipment and technology it needed to ramp up...
  2. Lonza Capsules & Health Ingredients expands capsule manufacturing capacity in India and China New capsule manufacturing lines added at Lonza Capsules & Health Ingredients (CHI) facilities in Rewari (IN) and Suzhou (CN), highlighting the long-term strategic commitment to...
  3. Novo Holdings completes acquisition of Catalent Novo Nordisk is a leading global healthcare company, founded in 1923 and headquartered in Denmark
  4. You need to be a subscriber to read this article.
    Click here to find out more.
    Industrial data mastery: navigating the 2025 landscape As industrial manufacturers contend with the ever-increasing volume and variety of operational data, the year ahead promises both complexity and opportunity
  5. Newcells Biotech raises additional funding from investors Newcells Biotech, a leading drug discovery partner specialising in the development of in vitro models and bespoke assay services to improve the prediction of in vivo human...

Upcoming event

EMPQ Essentials and Real-World Strategies for Successful Cleanroom Qualifications

16 January 2025 | Virtual See all

Related Content

Research & Development

Sterling Pharma broadens its ADC development services with £10m investment into Deeside site

The CDMO's ADC development and manufacturing facility in Deeside has more than doubled in capacity, with a new Grade C cleanroom dedicated to ADC manufacturing
Research & Development

Sterling Pharma Solutions announces partnership with Soligenix to manufacture oncology-targeted API

Sterling Pharma Solutions and Soligenix have announced a partnership that will see Sterling manufacture a GMP-quality synthetic hypericin developed by Soligenix for its oncology drug, HyBryte, in clinical trials
Manufacturing

Sterling Pharma Solutions and KGM Refrigeration partner to install sustainable chilling technology for API manufacturing

Sterling Pharma and KGM refrigeration have announced their partnership in a project to install a sustainable industrial ammonia-based cooling plant for use at API’s manufacturing plant in Cramlington, UK.
Finance

Sterling Pharma Solutions acquires UK CRO NewChem Technologies

Sterling Pharma Solutions has completed the acquisition of UK-based NewChem Technologies, a contract services provider focused on organic chemistry and supplying customers across a range of industries from pharmaceuticals, diagnostics and biotechnology to veterinary science and chemicals
Ingredients

Small molecules: big market opportunities

The rapid rise of biologic drugs in recent years has been accompanied by a market narrative that suggests that innovation and new treatments will be fuelled by breakthroughs in this area, leading to a decline in the small molecule pipeline. This is far from true, notes Kevin Cook, Chief Executive Officer at Sterling Pharma Solutions; both are increasing and small molecule drugs continue to be a mainstay of many drug development portfolios
Manufacturing

Sterling Pharma secures licence to manufacture ADCs

Sterling acquired a 6,500 sqm site as part of its purchase of ADC Biotechnology in April 2021, and has since gone on to invest in expanding the facility
Research & Development

Six strategies to streamline early phase small molecule API discovery and development

Proactive planning during the early phases of API development can help to mitigate any challenges that might arise later. Mat Minardi, Executive Vice President and Cary Site Head, and John Mykytiuk, Solid State Manager, both from Sterling Pharma Solutions, consider the benefits of working with an outsourcing partner to derisk the path to successful commercialisation
Subscribe now